(2026). TACE Combined with Targeted Immunotherapy: A Strategy for Liver Transplantation Conversion and Survival Benefits in Patients with BCLC Stage B/C HCC. Journal of Hepatocellular Carcinoma.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"TACE Combined with Targeted Immunotherapy: A Strategy for Liver Transplantation Conversion and Survival Benefits in Patients with BCLC Stage B/C HCC."
Journal of Hepatocellular Carcinoma 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"TACE Combined with Targeted Immunotherapy: A Strategy for Liver Transplantation Conversion and Survival Benefits in Patients with BCLC Stage B/C HCC."
Journal of Hepatocellular Carcinoma, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.